Complement inhibition: A possible therapeutic approach in the fight against Covid‐19-Reference-Cited by-同舟云学术

Complement inhibition: A possible therapeutic approach in the fight against Covid‐19

Published:2021-12-07 Issue: Volume: Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

Deravi Niloofar¹,Ahsan Elahe¹,Fathi Mobina¹,Hosseini Parastoo²,Yaghoobpoor Shirin¹,Lotfi Ramin³^ORCID,Pourbagheri‐Sigaroodi Atieh⁴,Bashash Davood⁴^ORCID

Affiliation:

1. Student Research Committee, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

2. Department of Virology, School of Public Health Tehran University of Medical Sciences Tehran Iran

3. Clinical Research Development Center Tohid Hospital, Kurdistan University of Medical Sciences Sanandaj Iran

4. Department of Hematology and Blood Banking, School of Allied Medical Sciences Shahid Beheshti University of Medical Sciences Tehran Iran

Funder

Shahid Beheshti University of Medical Sciences

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2316

Reference127 articles.

1. Immunology of COVID-19: Current State of the Science

2. SARS‐CoV‐2 infection in patients with diabetes mellitus and hypertension: a systematic review;Deravi N;Rev Cardiovasc Med,2020

3. Complement as a target in COVID-19?

4. Complement: a key system for immune surveillance and homeostasis

5. New insights into the immune functions of complement

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for infliximab-induced infusion reactions based on a retrospective study of medical information;Int. Journal of Clinical Pharmacology and Therapeutics;2024-07-01

2. The development of anticyclic citrullinated peptide (anti‐CCP) antibody following severe COVID‐19;Immunity, Inflammation and Disease;2024-05

3. Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 Infection;The Journal of Infectious Diseases;2023-10-25

4. Assessing the gene expression of the adenosine 5′-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients;Molecular Biology Reports;2023-10-24

5. Hyper‐inflammation and complement in COVID‐19;American Journal of Hematology;2023-03-31